Good
Mostly Aligned
Patient Risk:
Low
Summary
Most claims align with the provided FDA label excerpts for DEMADEX (torsemide) indicating treatment of edema associated with congestive heart failure, renal disease, and hepatic disease, including chronic renal failure; however, the label excerpts provided do not explicitly state that torsemide is a “loop diuretic,” nor do they explicitly describe use for “other causes of edema.”
Category Scores
Accurate Statements
Demadex is the brand name for the drug torsemide.
Supported insofar as the label excerpt identifies the product as DEMADEX (torsemide) tablets; however, the provided excerpts do not explicitly include the exact statement wording.
Torsemide is used as a diuretic to help the body get rid of extra fluid.
Supported by INDICATIONS AND USAGE describing treatment of edema and by DOSAGE/ADMINISTRATION context of diuretic response (label text provided implies diuresis for edema).
Torsemide is used for fluid buildup from heart failure.
INDICATIONS AND USAGE: “DEMADEX is indicated for the treatment of edema associated with congestive heart failure, renal disease, or hepatic disease.”
Torsemide is used for other causes of edema.
Partially supported: INDICATIONS AND USAGE specifies edema associated with renal disease and hepatic disease in addition to congestive heart failure; it does not support the broader phrasing “other causes” beyond those listed.
Unsupported Statements
Demadex (torsemide) is a loop diuretic.
The provided label excerpts do not explicitly use the term “loop diuretic.”
Torsemide is used for other causes of edema.
The label excerpts specifically list edema associated with congestive heart failure, renal disease, or hepatic disease; they do not support a general claim covering “other causes” of edema beyond those indications.
Contradictions
Important Omissions
If the intent was to list full on-label indications, the response omitted that DEMADEX is also indicated for hypertension alone or in combination with other antihypertensive agents (INDICATIONS AND USAGE).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The statements largely describe general on-label edema use (heart failure, renal disease, hepatic disease), but the “loop diuretic” terminology and broad “other causes of edema” wording are not explicitly supported by the provided label excerpts; omission of hypertension indication is not directly safety-critical.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Overbroad/unsupported phrasing: “loop diuretic” and “other causes of edema” are not explicitly supported by the provided label excerpts.
Suggested Improvement
Replace “loop diuretic” with label-supported mechanism/indication wording, and specify edema indications as “associated with congestive heart failure, renal disease, or hepatic disease” rather than “other causes of edema.”